| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.54e-10 | 37 | 83 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.88e-10 | 38 | 83 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | zinc ion binding | UBR1 RBSN ZGRF1 MYT1 UBR4 CSRP1 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 CLPX ERVK-24 PDZRN3 | 3.50e-06 | 891 | 83 | 15 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.12e-05 | 11 | 83 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.44e-05 | 14 | 83 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 8.73e-05 | 21 | 83 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | transition metal ion binding | UBR1 RBSN ZGRF1 MYT1 UBR4 CSRP1 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 CLPX ERVK-24 PDZRN3 | 1.02e-04 | 1189 | 83 | 15 | GO:0046914 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 4.86e-04 | 37 | 83 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 5.26e-04 | 38 | 83 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 7.52e-04 | 10 | 83 | 2 | GO:0140031 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 9.16e-04 | 11 | 83 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 9.24e-04 | 46 | 83 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | structural molecule activity | ANK2 ANK3 COL6A6 CSRP1 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 | 1.12e-03 | 891 | 83 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.08e-03 | 430 | 83 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.50e-03 | 136 | 83 | 4 | GO:0004519 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.72e-03 | 230 | 83 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.77e-03 | 231 | 83 | 5 | GO:0005085 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 5.36e-06 | 29 | 83 | 4 | GO:1903779 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.75e-05 | 13 | 83 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | protein localization to endoplasmic reticulum | 3.14e-05 | 90 | 83 | 5 | GO:0070972 | |
| GeneOntologyBiologicalProcess | regulation of SA node cell action potential | 4.79e-05 | 3 | 83 | 2 | GO:0098907 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell action potential | 9.55e-05 | 4 | 83 | 2 | GO:0098910 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 9.55e-05 | 4 | 83 | 2 | GO:0071596 | |
| GeneOntologyBiologicalProcess | regulation of AV node cell action potential | 1.59e-04 | 5 | 83 | 2 | GO:0098904 | |
| GeneOntologyCellularComponent | Z disc | 3.29e-05 | 151 | 84 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 5.58e-05 | 166 | 84 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | dynein axonemal particle | 6.79e-05 | 20 | 84 | 3 | GO:0120293 | |
| GeneOntologyCellularComponent | sarcomere | 5.03e-04 | 249 | 84 | 6 | GO:0030017 | |
| GeneOntologyCellularComponent | protein folding chaperone complex | 6.42e-04 | 42 | 84 | 3 | GO:0101031 | |
| GeneOntologyCellularComponent | myofibril | 8.14e-04 | 273 | 84 | 6 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.11e-03 | 290 | 84 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | A band | 1.20e-03 | 52 | 84 | 3 | GO:0031672 | |
| Domain | NUT | 5.70e-07 | 5 | 73 | 3 | IPR024310 | |
| Domain | NUT_N | 5.70e-07 | 5 | 73 | 3 | IPR024309 | |
| Domain | NUT | 5.70e-07 | 5 | 73 | 3 | PF12881 | |
| Domain | ZU5 | 4.73e-06 | 9 | 73 | 3 | SM00218 | |
| Domain | ZU5 | 6.74e-06 | 10 | 73 | 3 | PS51145 | |
| Domain | ZU5 | 1.23e-05 | 12 | 73 | 3 | PF00791 | |
| Domain | ZU5_dom | 1.23e-05 | 12 | 73 | 3 | IPR000906 | |
| Domain | ATP_Ca_trans_C | 9.00e-05 | 4 | 73 | 2 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 9.00e-05 | 4 | 73 | 2 | PF12424 | |
| Domain | P-type_ATPase_IIB | 9.00e-05 | 4 | 73 | 2 | IPR006408 | |
| Domain | DEATH | 1.57e-04 | 27 | 73 | 3 | SM00005 | |
| Domain | Death | 2.87e-04 | 33 | 73 | 3 | PF00531 | |
| Domain | ZF_UBR | 3.12e-04 | 7 | 73 | 2 | PS51157 | |
| Domain | zf-UBR | 3.12e-04 | 7 | 73 | 2 | PF02207 | |
| Domain | Znf_UBR | 3.12e-04 | 7 | 73 | 2 | IPR003126 | |
| Domain | ZnF_UBR1 | 3.12e-04 | 7 | 73 | 2 | SM00396 | |
| Domain | TPR_1 | 4.26e-04 | 90 | 73 | 4 | PF00515 | |
| Domain | TPR_1 | 4.26e-04 | 90 | 73 | 4 | IPR001440 | |
| Domain | Death_domain | 4.38e-04 | 38 | 73 | 3 | IPR000488 | |
| Domain | DEATH_DOMAIN | 4.38e-04 | 38 | 73 | 3 | PS50017 | |
| Domain | Elongated_TPR_rpt_dom | 8.10e-04 | 11 | 73 | 2 | IPR023114 | |
| Domain | - | 1.30e-03 | 207 | 73 | 5 | 1.25.40.10 | |
| Domain | TPR | 1.64e-03 | 129 | 73 | 4 | SM00028 | |
| Domain | - | 1.75e-03 | 16 | 73 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 1.75e-03 | 16 | 73 | 2 | IPR023298 | |
| Domain | TPR_repeat | 1.83e-03 | 133 | 73 | 4 | IPR019734 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.97e-03 | 17 | 73 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.97e-03 | 17 | 73 | 2 | PF00689 | |
| Domain | TPR-like_helical_dom | 2.18e-03 | 233 | 73 | 5 | IPR011990 | |
| Domain | Cation_ATPase_N | 2.21e-03 | 18 | 73 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 2.21e-03 | 18 | 73 | 2 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.47e-03 | 19 | 73 | 2 | IPR004014 | |
| Domain | TPR-contain_dom | 2.83e-03 | 150 | 73 | 4 | IPR013026 | |
| Domain | TPR_REGION | 3.98e-03 | 165 | 73 | 4 | PS50293 | |
| Domain | TPR | 3.98e-03 | 165 | 73 | 4 | PS50005 | |
| Domain | - | 5.78e-03 | 93 | 73 | 3 | 1.10.533.10 | |
| Domain | DEATH-like_dom | 6.87e-03 | 99 | 73 | 3 | IPR011029 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 3.21e-09 | 94 | 84 | 7 | 21542922 | |
| Pubmed | 1.54e-08 | 12 | 84 | 4 | 14557543 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 5.43e-08 | 4 | 84 | 3 | 10469592 | |
| Pubmed | 9.44e-08 | 18 | 84 | 4 | 18664271 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.35e-07 | 5 | 84 | 3 | 12629516 | |
| Pubmed | The RPAP3-Cterminal domain identifies R2TP-like quaternary chaperones. | 2.70e-07 | 6 | 84 | 3 | 29844425 | |
| Pubmed | 1.57e-06 | 335 | 84 | 8 | 15741177 | ||
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 1.61e-06 | 10 | 84 | 3 | 22159418 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 NCOA3 SETD2 RNF169 C9orf78 MKI67 CCAR1 DIDO1 UNC5D EMSY C2CD5 | 2.62e-06 | 774 | 84 | 11 | 15302935 |
| Pubmed | SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer. | 2.94e-06 | 12 | 84 | 3 | 31911863 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SETD2 RNF169 RUVBL1 BCORL1 MKI67 CCAR1 DIDO1 BOD1L1 LAS1L SRFBP1 IMMT EMSY | 3.12e-06 | 954 | 84 | 12 | 36373674 |
| Pubmed | PPP1R7 NCOA3 MIA3 ANK2 ANK3 UBR4 ARHGEF12 CCAR1 DIDO1 CDK5RAP2 ATP2B4 EMSY | 3.44e-06 | 963 | 84 | 12 | 28671696 | |
| Pubmed | 3.63e-06 | 503 | 84 | 9 | 16964243 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 1531651 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 11781319 | ||
| Pubmed | Structural basis of diverse membrane target recognitions by ankyrins. | 5.76e-06 | 2 | 84 | 2 | 25383926 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 18547816 | ||
| Pubmed | Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth. | 6.06e-06 | 15 | 84 | 3 | 30562487 | |
| Pubmed | RAB3GAP1 MIA3 ANK2 ANK3 GLG1 UBR4 RTN3 CDK5RAP2 BOP1 CLPX LAS1L IMMT ATP2B4 C2CD5 | 1.23e-05 | 1487 | 84 | 14 | 33957083 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.31e-05 | 212 | 84 | 6 | 33853758 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.65e-05 | 608 | 84 | 9 | 36089195 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 15611082 | ||
| Pubmed | Human ankyrins and their contribution to disease biology: An update. | 1.73e-05 | 3 | 84 | 2 | 33410423 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 27005929 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 12571286 | ||
| Pubmed | Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue. | 1.73e-05 | 3 | 84 | 2 | 34289389 | |
| Pubmed | METTL3-mediated m6A modification is required for cerebellar development. | 1.75e-05 | 21 | 84 | 3 | 29879109 | |
| Pubmed | RBSN RAB3GAP1 MIA3 RUVBL1 ANK2 ANK3 GLG1 UBR4 FAM169A MKLN1 RTN3 RYR2 | 1.85e-05 | 1139 | 84 | 12 | 36417873 | |
| Pubmed | Single-cell gene profiling defines differential progenitor subclasses in mammalian neurogenesis. | 2.43e-05 | 69 | 84 | 4 | 18725516 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.80e-05 | 361 | 84 | 7 | 26167880 | |
| Pubmed | 3.38e-05 | 251 | 84 | 6 | 29778605 | ||
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 3.45e-05 | 4 | 84 | 2 | 12209837 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 24821222 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 12784250 | ||
| Pubmed | A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons. | 3.45e-05 | 4 | 84 | 2 | 16055722 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 15101689 | ||
| Pubmed | The substrate recognition domains of the N-end rule pathway. | 3.45e-05 | 4 | 84 | 2 | 19008229 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 3.45e-05 | 4 | 84 | 2 | 8245032 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 10577388 | ||
| Pubmed | An integrative genomic analysis of the Longshanks selection experiment for longer limbs in mice. | 3.45e-05 | 4 | 84 | 2 | 31169497 | |
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 3.45e-05 | 4 | 84 | 2 | 8634322 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 3.45e-05 | 4 | 84 | 2 | 7989379 | |
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 3.45e-05 | 4 | 84 | 2 | 11152753 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 7983737 | ||
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 3.45e-05 | 4 | 84 | 2 | 36130203 | |
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 3.45e-05 | 4 | 84 | 2 | 10434059 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 25950943 | ||
| Pubmed | Glial ankyrins facilitate paranodal axoglial junction assembly. | 5.74e-05 | 5 | 84 | 2 | 25362471 | |
| Pubmed | PLK1-dependent activation of LRRK1 regulates spindle orientation by phosphorylating CDK5RAP2. | 5.74e-05 | 5 | 84 | 2 | 26192437 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 17938178 | ||
| Pubmed | An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan. | 5.74e-05 | 5 | 84 | 2 | 19109891 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PPP1R7 RUVBL1 ICA1 UBR4 MKLN1 BOP1 LRRK1 CLPX LAS1L KLC4 MAST2 C2CD5 | 5.92e-05 | 1284 | 84 | 12 | 17353931 |
| Pubmed | MIA3 ANK3 GLG1 ICA1 MKLN1 HIPK2 DIDO1 CDK5RAP2 BOP1 BOD1L1 C2CD5 | 5.96e-05 | 1084 | 84 | 11 | 11544199 | |
| Pubmed | 6.05e-05 | 87 | 84 | 4 | 33798452 | ||
| Pubmed | 6.45e-05 | 282 | 84 | 6 | 23667531 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 6.57e-05 | 283 | 84 | 6 | 30585729 | |
| Pubmed | Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation. | 7.70e-05 | 34 | 84 | 3 | 30726710 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 23824717 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 15063128 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 20188654 | ||
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 8.59e-05 | 6 | 84 | 2 | 23728480 | |
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 8.59e-05 | 6 | 84 | 2 | 12767889 | |
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 9.16e-05 | 36 | 84 | 3 | 26053890 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 9.69e-05 | 440 | 84 | 7 | 34244565 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.08e-04 | 38 | 84 | 3 | 30786075 | |
| Pubmed | 1.08e-04 | 101 | 84 | 4 | 26949739 | ||
| Pubmed | RUVBL1 ANK2 NEMF MKI67 CCAR1 DIDO1 BOP1 CLPX LAS1L SRFBP1 PRPF39 ATP2B4 | 1.10e-04 | 1371 | 84 | 12 | 36244648 | |
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 1.20e-04 | 7 | 84 | 2 | 7495297 | |
| Pubmed | The N-terminal cysteine is a dual sensor of oxygen and oxidative stress. | 1.20e-04 | 7 | 84 | 2 | 34893540 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 28799057 | ||
| Pubmed | 1.26e-04 | 40 | 84 | 3 | 28805822 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RUVBL1 UBR4 NEMF MKI67 CCAR1 RTN3 BOP1 BOD1L1 CLPX MAST2 ATP2B3 IMMT | 1.58e-04 | 1425 | 84 | 12 | 30948266 |
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 10951186 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 18084280 | ||
| Pubmed | NCOA3 GLI3 UBR4 BCORL1 MKI67 HIPK2 CCAR1 DIDO1 CLPX LAS1L IMMT EMSY | 1.62e-04 | 1429 | 84 | 12 | 35140242 | |
| Pubmed | 1.67e-04 | 1014 | 84 | 10 | 32416067 | ||
| Pubmed | 1.68e-04 | 44 | 84 | 3 | 27505670 | ||
| Pubmed | Gli3 null mice display glandular overgrowth of the developing stomach. | 2.05e-04 | 9 | 84 | 2 | 16247775 | |
| Pubmed | Potent and specific Atg8-targeting autophagy inhibitory peptides from giant ankyrins. | 2.05e-04 | 9 | 84 | 2 | 29867141 | |
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 23829686 | ||
| Pubmed | Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation. | 2.05e-04 | 9 | 84 | 2 | 17855541 | |
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 25653379 | ||
| Pubmed | 2.17e-04 | 121 | 84 | 4 | 22412018 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.47e-04 | 361 | 84 | 6 | 30344098 | |
| Pubmed | Comparative mapping in the beige-satin region of mouse chromosome 13. | 2.56e-04 | 10 | 84 | 2 | 9027500 | |
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 38358805 | ||
| Pubmed | A role for primary cilia in aortic valve development and disease. | 2.56e-04 | 10 | 84 | 2 | 28556366 | |
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 37577930 | ||
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 12970426 | ||
| Pubmed | 2.60e-04 | 233 | 84 | 5 | 37704626 | ||
| Pubmed | Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative Stress. | 2.76e-04 | 52 | 84 | 3 | 28947420 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 2.85e-04 | 130 | 84 | 4 | 35545047 | |
| Pubmed | Gli3 is required for maintenance and fate specification of cortical progenitors. | 3.13e-04 | 11 | 84 | 2 | 21525285 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DNAAF2 PPP1R7 NCOA3 SPAG1 ANK3 GLI3 MKLN1 RPGR LAS1L KLC4 IMMT | 3.33e-04 | 1321 | 84 | 11 | 27173435 |
| Pubmed | 3.58e-04 | 250 | 84 | 5 | 33536335 | ||
| Pubmed | 3.75e-04 | 12 | 84 | 2 | 18582859 | ||
| Pubmed | Divergent regulation of functionally distinct γ-tubulin complexes during differentiation. | 3.75e-04 | 12 | 84 | 2 | 27298324 | |
| Pubmed | 3.75e-04 | 12 | 84 | 2 | 35472321 | ||
| Pubmed | A role for proneural genes in the maturation of cortical progenitor cells. | 3.75e-04 | 12 | 84 | 2 | 16766700 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.05e-04 | 7 | 41 | 2 | 785 | |
| GeneFamily | ATPases Ca2+ transporting | 1.79e-04 | 9 | 41 | 2 | 1209 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.24e-03 | 115 | 41 | 3 | 769 | |
| GeneFamily | PDZ domain containing | 4.92e-03 | 152 | 41 | 3 | 1220 | |
| GeneFamily | AAA ATPases | 6.43e-03 | 53 | 41 | 2 | 413 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.96e-03 | 181 | 41 | 3 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.82e-03 | 66 | 41 | 2 | 722 | |
| GeneFamily | Ankyrin repeat domain containing | 1.74e-02 | 242 | 41 | 3 | 403 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | UBR1 ZGRF1 GLI3 MKI67 FAM169A ARHGEF12 CCAR1 RTN3 DIDO1 CDK5RAP2 BOD1L1 SRFBP1 | 1.69e-06 | 629 | 74 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | NCOA3 SETD2 RBSN MKI67 MKLN1 HIPK2 ARHGEF12 CCAR1 CLPX MAST2 EMSY C2CD5 | 1.50e-05 | 780 | 74 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | COL6A6 GLI3 ICA1 MKI67 FAM169A HIPK2 CCAR1 GPSM2 BOD1L1 RPGR PRPF39 DKKL1 PDZRN3 EMSY | 9.32e-05 | 1252 | 74 | 14 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.11e-04 | 71 | 74 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | GLI3 MYT1 ICA1 MKI67 FAM169A ARHGEF12 CCAR1 CDK5RAP2 BOD1L1 RPGR PPP1R15A GPR179 | 1.48e-04 | 989 | 74 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.58e-04 | 146 | 74 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.37e-09 | 189 | 77 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 3.87e-08 | 189 | 77 | 7 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.02e-08 | 190 | 77 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 4.32e-08 | 192 | 77 | 7 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.80e-08 | 195 | 77 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.20e-07 | 176 | 77 | 6 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 9.99e-07 | 191 | 77 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.06e-06 | 193 | 77 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.13e-06 | 195 | 77 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-06 | 195 | 77 | 6 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-06 | 195 | 77 | 6 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 171 | 77 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.56e-05 | 181 | 77 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.60e-05 | 182 | 77 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.73e-05 | 185 | 77 | 5 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.78e-05 | 186 | 77 | 5 | 55b239834b96b1f7787ec77a7d19796d617bbbf0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.78e-05 | 186 | 77 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-05 | 189 | 77 | 5 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.92e-05 | 189 | 77 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-05 | 189 | 77 | 5 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-05 | 189 | 77 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.97e-05 | 190 | 77 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-05 | 191 | 77 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 192 | 77 | 5 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 192 | 77 | 5 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-05 | 192 | 77 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.07e-05 | 192 | 77 | 5 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 192 | 77 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-05 | 192 | 77 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.07e-05 | 192 | 77 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.17e-05 | 194 | 77 | 5 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.17e-05 | 194 | 77 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 194 | 77 | 5 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.17e-05 | 194 | 77 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 194 | 77 | 5 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-05 | 196 | 77 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-05 | 197 | 77 | 5 | fd43fc1cbf0c17b370397d73dddc572565a759c7 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.34e-05 | 197 | 77 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.40e-05 | 198 | 77 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.40e-05 | 198 | 77 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.46e-05 | 199 | 77 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.52e-05 | 200 | 77 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.55e-04 | 156 | 77 | 4 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 161 | 77 | 4 | a7e74bc80ac11250e353e5614b19c05793fc2e95 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-04 | 162 | 77 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | normal_Lung-Epithelial_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 1.87e-04 | 164 | 77 | 4 | fa2dae15b38cb8f9642dbf00549beec8ee19e9bb | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-04 | 165 | 77 | 4 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 2.01e-04 | 167 | 77 | 4 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.05e-04 | 168 | 77 | 4 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 170 | 77 | 4 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-04 | 173 | 77 | 4 | 3001dd39244ef0a5a475d569a78f4ae427a55db6 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 2.30e-04 | 173 | 77 | 4 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-04 | 173 | 77 | 4 | c88883fb2a33e21d4201aa393674aa3f2ad780c9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-04 | 175 | 77 | 4 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-04 | 175 | 77 | 4 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-04 | 175 | 77 | 4 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.45e-04 | 176 | 77 | 4 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-04 | 177 | 77 | 4 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.61e-04 | 179 | 77 | 4 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.73e-04 | 181 | 77 | 4 | c18e5a3f5d99043fa3cb33e2ac33fa98cd15d3db | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 181 | 77 | 4 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 182 | 77 | 4 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 2.84e-04 | 183 | 77 | 4 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-04 | 183 | 77 | 4 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.84e-04 | 183 | 77 | 4 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.84e-04 | 183 | 77 | 4 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 184 | 77 | 4 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 184 | 77 | 4 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.90e-04 | 184 | 77 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-04 | 184 | 77 | 4 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.90e-04 | 184 | 77 | 4 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-04 | 184 | 77 | 4 | 2c286712428662bc4589dc5ac4011bf7ed403cb5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 185 | 77 | 4 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-04 | 185 | 77 | 4 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.96e-04 | 185 | 77 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-04 | 186 | 77 | 4 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-04 | 186 | 77 | 4 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-04 | 187 | 77 | 4 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.15e-04 | 188 | 77 | 4 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-04 | 188 | 77 | 4 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.15e-04 | 188 | 77 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 3.15e-04 | 188 | 77 | 4 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 188 | 77 | 4 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 3.15e-04 | 188 | 77 | 4 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.15e-04 | 188 | 77 | 4 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.15e-04 | 188 | 77 | 4 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 189 | 77 | 4 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.21e-04 | 189 | 77 | 4 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.21e-04 | 189 | 77 | 4 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 189 | 77 | 4 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.21e-04 | 189 | 77 | 4 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 189 | 77 | 4 | 31d34bc75d4457fca197e1766922e987dbd5f8a9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.21e-04 | 189 | 77 | 4 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-04 | 190 | 77 | 4 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 3.28e-04 | 190 | 77 | 4 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 9.25e-05 | 6 | 74 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | cerebrospinal fluid biomarker measurement, monocyte chemotactic protein 1 measurement | 9.25e-05 | 6 | 74 | 2 | EFO_0006794, EFO_0010596 | |
| Disease | Primary Ciliary Dyskinesia | 2.27e-04 | 47 | 74 | 3 | C4551720 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 2.76e-04 | 10 | 74 | 2 | C1631597 | |
| Disease | non-alcoholic steatohepatitis | 4.03e-04 | 12 | 74 | 2 | EFO_1001249 | |
| Disease | sporadic amyotrophic lateral sclerosis | 4.32e-04 | 140 | 74 | 4 | EFO_0001357 | |
| Disease | YKL40 measurement | 6.38e-04 | 15 | 74 | 2 | EFO_0004869 | |
| Disease | intellectual disability (implicated_via_orthology) | 8.98e-04 | 75 | 74 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | testosterone measurement | 1.27e-03 | 1275 | 74 | 10 | EFO_0004908 | |
| Disease | Malignant neoplasm of breast | 1.44e-03 | 1074 | 74 | 9 | C0006142 | |
| Disease | amino acid measurement | 1.56e-03 | 678 | 74 | 7 | EFO_0005134 | |
| Disease | cortical surface area measurement | ZAN ANK3 GLI3 MYT1 MACROD2 HIPK2 ARHGEF12 CCAR1 MAST2 PDZRN3 | 1.89e-03 | 1345 | 74 | 10 | EFO_0010736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDDEGHSGIKKTTEE | 86 | Q14137 | |
| LGGKEDSDSELEITD | 311 | A0A1W2PQ73 | |
| AEGLSEKSGKHVSAE | 681 | Q5RHP9 | |
| GGEVLDSSHDDIKLE | 271 | O76031 | |
| EKDDGEAKEISTPTH | 616 | Q8IX12 | |
| PDGSATEKLGHKSED | 76 | Q5H9F3 | |
| DDTLVGKADEKASEH | 281 | Q6ZMI3 | |
| KEHSILVEESSGELE | 131 | Q6P1W5 | |
| DLKIDESSLTGESDH | 236 | Q16720 | |
| DLKIDESSLTGESDH | 231 | P23634 | |
| EEDPSKLKEEQHGIS | 1156 | Q9NZN5 | |
| AKEQHTDGTLKEVGE | 1216 | Q9NZN5 | |
| EQEVSGEHLDGKTEK | 811 | Q96SN8 | |
| EEEGKETADITHALS | 351 | Q15042 | |
| KKHDEDGGTTDTATI | 546 | Q9UPQ7 | |
| EHSGEDRDVKGQIKS | 36 | Q9H1K0 | |
| EKEHPTTKDITGGSE | 2276 | Q01484 | |
| GKSEEEKDSESHLAE | 2731 | Q01484 | |
| SLALQGTHEKDTEGE | 2811 | Q01484 | |
| GTHEKDTEGEELDVS | 2816 | Q01484 | |
| HTSEEKEGDATKDSL | 161 | Q9NSK0 | |
| EGTTLVKEEGDKDES | 456 | P10071 | |
| EKHLEISREVGDKSG | 346 | P81274 | |
| PDDHEAETGIKSKEA | 451 | Q9H2X6 | |
| SDSGDLEALEGKDKE | 831 | O60524 | |
| EVAEGHSLEATEKGD | 1901 | Q6PRD1 | |
| TEEKETDGDHLSSLL | 776 | Q9NVR5 | |
| SKLEHSEDEGSVLGQ | 1236 | Q38SD2 | |
| GEKHLGVEIEKTSGE | 121 | Q9C098 | |
| KGTHKDVLEEGTESS | 206 | Q9UK85 | |
| STDKGESLGIKHEEA | 81 | P21291 | |
| EESLKTDHPEIGEGK | 166 | Q16891 | |
| KADGDSKGSEEVDSH | 241 | Q9Y4W2 | |
| ETTHTDKVPGGEDKS | 1416 | P46013 | |
| GSEEPEEKKAHTEDT | 611 | Q86UA1 | |
| THLATGESDGKQEEE | 381 | Q86Y26 | |
| GTEDSALHGIEELKK | 151 | Q14397 | |
| ETELHSSEKGLKVEE | 756 | Q8NFC6 | |
| GSELHEIIDKSRKEG | 261 | P87889 | |
| GSELHEIIDKSRKEG | 261 | Q9YNA8 | |
| GSELHEIIDKSRKEG | 261 | P62683 | |
| GSELHEIIDKSRKEG | 261 | P63145 | |
| GSELHEIIDKSRKEG | 261 | P63130 | |
| GSELHEIIDKSRKEG | 261 | P62685 | |
| GSELHEIIDKSRKEG | 261 | P63126 | |
| GSELHEIIDKSRKEG | 261 | P62684 | |
| HGILTKAKDDSELEG | 951 | Q92896 | |
| GSVDKIPDKDHLSEE | 126 | A0A1B0GVN3 | |
| HIEASEDGEFTVKGK | 406 | Q2M3T9 | |
| KVKGGDDHDDTSDSD | 141 | Q9BTC0 | |
| DVSENGVGKVSKDEH | 2521 | Q12955 | |
| EGTSDEKGHMEEKLS | 501 | Q9Y6X4 | |
| TKRSLSEEKEDHSDG | 871 | Q6P0Q8 | |
| SEEKEDHSDGLAGLK | 876 | Q6P0Q8 | |
| FTKHSEELGTEEGEV | 911 | Q7Z589 | |
| TETKEGDVTDEHGER | 36 | Q8IZT9 | |
| DGDHDKLSKRLGEVE | 1306 | D6RIA3 | |
| RVESEESGDEEGKKH | 21 | Q15435 | |
| EGKKHSSGIVADLSE | 31 | Q15435 | |
| TVTLGDEKGKVHESI | 1466 | Q92736 | |
| SSDEVTELDLSHGKK | 661 | Q86YS7 | |
| GETSHLDGEILKKES | 2091 | A6NMZ7 | |
| EASEEKEEKAHKETG | 266 | O75807 | |
| TGKKEDEHVVASDAD | 41 | Q05084 | |
| KDENITKGGEVTDHS | 306 | A1Z1Q3 | |
| KESHGLAKGSSEETE | 621 | A1L443 | |
| KESHGLAKGSSEETE | 606 | Q5VZR2 | |
| HGGRKEKTEILSDDL | 821 | Q92834 | |
| EVLHENESGGSEIKD | 691 | O95197 | |
| PEGELSKEDHENTEK | 871 | Q5JRA6 | |
| DSDHVDIISDGTKKD | 491 | Q9UL63 | |
| DHLSDKESKESSVEG | 591 | Q9Y6Q9 | |
| EELLGSEGIHSSKEK | 461 | Q8NCN4 | |
| STEEEAKGSGQDIDH | 531 | Q13972 | |
| GSELHEIIDKSRKEG | 261 | P63128 | |
| VEAGTLKHEEKGENE | 331 | Q8IUQ0 | |
| SLSGEDKREHRGKEE | 251 | Q8IWX7 | |
| RHKDGGYSEEEDVKT | 56 | Q8WYP3 | |
| KHDSIDETLEDSIGI | 306 | A4D1E1 | |
| SHKDDVKEGEGGQES | 906 | Q9BZQ8 | |
| EKVFLKEDTGETHGD | 311 | Q8NEF9 | |
| KEDTGETHGDTRNDK | 316 | Q8NEF9 | |
| NSEDEEGKSGRKHED | 346 | Q07617 | |
| GSESIKNDEITHDKE | 1001 | Q8IWV7 | |
| EHVSEETLDESSGLK | 96 | Q6UXZ4 | |
| KEDSHIGKDEEIPDS | 281 | Q9BYW2 | |
| LKHAGKETIVEVGSD | 921 | Q9BYW2 | |
| ATSELEGKDGKEDLD | 1896 | Q9BYW2 | |
| GKDSIEKEHVEEISE | 421 | Q9Y265 | |
| KDTEAHISEPEDLGK | 776 | Q86YA3 | |
| GKDKISEEEDLHLGT | 86 | Q9NZ63 | |
| VESHEKSLGEADKAD | 91 | P01270 | |
| LTTDLDGEDEKDKGA | 3006 | Q5T4S7 | |
| DHLKLDGSPAGDKEE | 1301 | Q9Y493 | |
| EESSKQKGILSHEEE | 246 | Q01538 |